AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 292: F1560-F1567, 2007. First published January 30, 2007; doi:10.1152/ajprenal.00213.2006
0363-6127/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/5/F1560    most recent
00213.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aigner, B.
Right arrow Articles by Wolf, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aigner, B.
Right arrow Articles by Wolf, E.

Screening for increased plasma urea levels in a large-scale ENU mouse mutagenesis project reveals kidney disease models

Bernhard Aigner,1 Birgit Rathkolb,1 Nadja Herbach,2 Elisabeth Kemter,2 Christina Schessl,1 Matthias Klaften,3 Martina Klempt,1 Martin Hrabé de Angelis,3 Rüdiger Wanke,2 and Eckhard Wolf1

1Institute of Molecular Animal Breeding and Biotechnology and 2Institute of Veterinary Pathology, Ludwig Maximilians University, Munich; and 3Institute of Experimental Genetics, GSF Research Center for Environment and Health, Neuherberg, Germany

Submitted 13 June 2006 ; accepted in final form 18 January 2007

Kidney diseases lead to the failure of urinary excretion of metabolism products. In the Munich ethylnitrosourea (ENU) mouse mutagenesis project, which is done on a C3H inbred genetic background, blood samples of more than 15,000 G1 offspring and 500 G3 pedigrees were screened for alterations in clinical-chemical parameters. We identified 44 animals consistently exhibiting increased plasma urea concentrations. Transmission analysis of the altered phenotype of 23 mice to subsequent generations led to the establishment of five mutant lines. Both sexes were affected in these lines. Urinary urea levels were decreased in the mutants. In addition, most mutants showed increased plasma and decreased urinary creatinine levels. Pathological investigation of kidneys from the five mutant lines revealed a broad spectrum of alterations, ranging from no macroscopic and light microscopic kidney alterations to decreased kidney weight-to-body weight ratio, dilation of the renal pelvis, and severe glomerular lesions. Thus screening for elevated plasma urea levels in a large-scale ENU mouse mutagenesis project resulted in the successful establishment of mouse strains which are valuable tools for molecular studies of mechanisms involved in urea excretion or which represent interesting models for kidney diseases.

ethylnitrosourea; nephropathy; renal failure



Address for reprint requests and other correspondence: B. Aigner, Institute of Molecular Animal Breeding and Biotechnology, Hackerstr. 27, D-85764 Oberschleissheim, Germany (e-mail: b.aigner{at}gen.vetmed.uni-muenchen.de)




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Aigner, B. Rathkolb, N. Herbach, M. H. de Angelis, R. Wanke, and E. Wolf
Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E232 - E240.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.